First American Scientific Corp. (fka FASC)

[TRCPA]

As for margins on sales, the selling prices of new KDS appear to be starting at about $300K. Margins on these sales are about $150-$175K from what I can see. These are on direct sales for FASC that are not part of the overseas joint ventures and licensees of which FASC is a part of. Sales prices have been and continue to be on the rise as new R&D have been added to the value of the KDS.

There are overseas joint ventures and licensees that have been paying FASC royalties of $25K to $50K per sale in Malaysia, Korea, Japan, and Brazil. Also, there are two of these joint ventures....in Malaysia and Korea..... in which FASC will split the remaining profits with the other joint venture partners on a 50/50 ratio.

So its a mix of direct sales, royalties, and profits from joint ventures that make up the current revenue mix for FASC, via sales from the KDS.